Last 644.00 INR
Change Today +7.60 / 1.19%
Volume 655.5K
IPCA On Other Exchanges
Symbol
Exchange
Natl India
As of 6:12 AM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

ipca laboratories ltd (IPCA) Snapshot

Open
639.70
Previous Close
636.40
Day High
649.50
Day Low
635.00
52 Week High
02/28/14 - 906.90
52 Week Low
11/5/14 - 630.00
Market Cap
81.3B
Average Volume 10 Days
532.0K
EPS TTM
37.92
Shares Outstanding
126.2M
EX-Date
07/18/14
P/E TM
17.0x
Dividend
2.50
Dividend Yield
0.78%
Current Stock Chart for IPCA LABORATORIES LTD (IPCA)

Related News

No related news articles were found.

ipca laboratories ltd (IPCA) Related Businessweek News

No Related Businessweek News Found

ipca laboratories ltd (IPCA) Details

Ipca Laboratories Limited manufactures and supplies pharmaceutical formulations and active pharmaceutical ingredients for various therapeutic segments in India. It offers branded and generic formulations in various dosage forms, including oral solids and liquids, dry powders for suspension, and liquid and dry injectables. The company provides formulations for various therapeutic areas, such as cardiovascular, anti-diabetic, cardio-diabetic, rheumatology, orthopaedics, dermatology, gastro-intestinal, anti-bacterial, pain and hypertension management, respiratory, urology, nutraceutical, neuropsychiatry, anti-malarial, anti-infective, cough, geriatric, and non steroid anti-inflammatory drugs, as well as oral and injectable antibiotics for surgical and non-surgical needs. It also offers drug intermediates. The company also exports its products to approximately 130 countries worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.

5,051 Employees
Last Reported Date: 05/30/09
Founded in 1949

ipca laboratories ltd (IPCA) Top Compensated Officers

Chairman, Chief Executive Officer, Managing D...
Total Annual Compensation: 30.0M
President of Apis & Generics and Executive Di...
Total Annual Compensation: 4.1M
Joint Managing Director, Executive Director a...
Total Annual Compensation: 6.0M
Executive Director and Member of Audit Commit...
Total Annual Compensation: 3.5M
Compensation as of Fiscal Year 2014.

ipca laboratories ltd (IPCA) Key Developments

Ipca Laboratories Limited, Q2 2015 Earnings Call, Nov 11, 2014

Ipca Laboratories Limited, Q2 2015 Earnings Call, Nov 11, 2014

Ipca Laboratories Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Ipca Laboratories Limited reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales/income from operations of INR 7,748.7 million against INR 8,389.1 million a year ago. Total income from operations (net) was INR 7,806.0 million against INR 8,467.0 million a year ago. Profit from operations before other income, foreign exchange transactions/translations gain, finance costs and exceptional items was INR 951.6 million against INR 2,093.1 million a year ago. Profit from ordinary activities before tax was INR 887.7 million against INR 1,690.0 million a year ago. Net profit from ordinary activities after tax was INR 613.0 million or INR 4.86 per basic and diluted per share against INR 1,294.5 million or INR 10.26 per basic and diluted per share a year ago. For the six months, the company reported net sales/income from operations of INR 17,030.7 million against INR 16,342.4 million a year ago. Total income from operations (net) was INR 17,165.6 million against INR 16,522.6 million a year ago. Profit from operations before other income, foreign exchange transactions/translations gain, finance costs and exceptional items was INR 2,881.7 million against INR 3,562.2 million a year ago. Profit from ordinary activities before tax was INR 2,846.1 million against INR 2,652.7 million a year ago. Net profit from ordinary activities after tax was INR 2,067.9 million or INR 16.39 per basic and diluted per share against INR 2,012.2 million or INR 15.94 per basic and diluted per share a year ago.

Ipca Laboratories Limited to Report Q2, 2015 Results on Nov 10, 2014

Ipca Laboratories Limited announced that they will report Q2, 2015 results on Nov 10, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPCA:IN 644.00 INR +7.60

IPCA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cadila Healthcare Ltd 1,660 INR +8.55
Cipla Ltd/India 703.55 INR -3.50
Lupin Ltd 1,516 INR -8.75
Torrent Pharmaceuticals Ltd 1,212 INR +30.00
Wockhardt Ltd 1,143 INR -1.35
View Industry Companies
 

Industry Analysis

IPCA

Industry Average

Valuation IPCA Industry Range
Price/Earnings 10.9x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 9.0x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IPCA LABORATORIES LTD, please visit www.ipcalabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.